The Health Catalysts Diagnostics Year in Review (2020)

The Health Catalysts Diagnostics Year in Review (2019)

The Health Catalysts Diagnostics Year in Review (2018)                                               

The Health Catalysts Diagnostics Year in Review (Prior Years)



“Structuring the Patient-Physician Encounter: Joint Creation of an Actionable Roadmap to Health Care”: The Journal of Delivery Science and Innovation, March 2014



“The Business Value and Cost – Effectiveness of Genomic Medicine”, Future Medicine, May 2012



“Gene Sequencing: Staking a Position in an Expanding Industry”, Harvard Business School Case, October 2011



“On-Target Treatment: Personalized medicine calls for new diagnostic tools and rules”, The Boston Globe, April 2011



“The Importance of Circulating Tumor Cells in diagnosis, prognosis and treatment decisions”, Clinical Advances in Hematology and Oncology, December 2010



“Plavix: Drugs in the Age of Personalized Medicine,” Harvard Business School Case, November 2010



“The Explosion of Genetic Testing: Opportunities and Challenges,” Harvard Business School Case, October 2009



“Personalized Medicine and Pathology – Friend or Foe”, Archives of Pathology Laboratory Medicine, April 2009



“Realizing the Promise of Personalized Medicine”, Harvard Business Review, October 2007



“Market Crossroads: Fertile Ground for Board Development”, The International Journal of Corporate Governance, 2002, Vol 2, No 2